Interview with Joël Guigay, MD, PhD | France - Prova Education

Interview with Joël Guigay, MD, PhD | France

Interview with Joël Guigay, MD, PhD | France

13

13

Overview
We sat down with Dr. Joël Guigay at the 2015 ECC conference in Vienna, Austria, where we discussed the emerging advances in induction and maintenance therapy in head and neck cancer.

Facebook Comments

Recommended

- Lyudmila Bazhenova, MD
  Peer
- Benjamin Levy, MD
  Peer
2
CME/CE
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
- Mark Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
3
CME/CE
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC
0.25 credits
Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunothera…
0.25 credits
- Daniel P. Petrylak, MD
  Peer
- Arlene O. Siefker-Radtke, MD
  Peer
4
CME/CE
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma
0.25 credits
Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or M…
0.25 credits
- Lauren Ritterhouse, MD ,PhD
  Peer
- Pasi Antero Jänne, MD, PhD
  Peer
- Kanwal Raghav, MD
  Peer
1
CME/CE
The Role of HER3 Expression in Advanced Solid Tumors
The Role of HER3 Expression in Advanced Solid Tumors
0.50 credits
The Role of HER3 Expression in Advanced Solid Tumors
0.50 credits